Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)

Q: How much funding does Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025) provide?

Funding amounts vary. Check the grant details for specifics.

Q: When is the deadline for Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)?

This grant has a rolling deadline or the deadline has not been announced.

AIDS VACCINE ADVOCACY COALITION INC

Foundation Grants for HIV/AIDS Grants for Science Research

Apply Now

Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)

Funder: National Institutes of Health (NIH)

Goal: An integrated, iterative multidisciplinary application for developing a microbicide, Pre-Exposure Prophylaxis (PrEP), or Multipurpose Prevention Technology (MPT) non-vaccine biomedical prevention (nBP) product or strategy.

Purpose: To solicit applications from single institutions and consortia of institutions to participate in the Integrated Preclinical Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP). The objective is to create an integrated and iterative multi-disciplinary application with the goal of developing biomedical HIV prevention products or strategies.

Focus Areas:

Microbicides for HIV prevention

Pre-Exposure Prophylaxis (PrEP)

Multipurpose Prevention Technologies (MPT)

Non-vaccine biomedical prevention strategies

Products for use in male and/or female genital and gastrointestinal (GI) tracts

Prevention of HIV acquisition and transmission

Product Delivery Systems:

Gels

Films

Quick dissolving tablets

Intravaginal rings (IVR)